Lisa Fetters, NP
Physician Assistant · Norfolk, VANPI 1104254473
Payments from drug & device makers
Across 226 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$771
- AbbVie$505
- Boehringer Ingelheim$482
- Novo Nordisk$460
- Pfizer$243
- GSK$241
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,90799%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 32 | $771 |
| AbbVie | 30 | $505 |
| Boehringer Ingelheim | 31 | $482 |
| Novo Nordisk | 27 | $460 |
| Pfizer | 14 | $243 |
| GSK | 15 | $241 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $147 |
| Amarin Pharma, Inc. | 10 | $144 |
| Esperion Therapeutics, Inc. | 8 | $120 |
| Amgen | 8 | $114 |
| Lilly USA, LLC | 5 | $76 |
| E.r. Squibb & Sons, L.L.C. | 5 | $74 |
| Astellas Pharma US Inc | 4 | $74 |
| Johnson & Johnson | 4 | $66 |
| Dexcom, Inc. | 3 | $49 |
| Boston Scientific | 3 | $49 |
| Bayer | 2 | $48 |
| Gilead | 1 | $43 |
| Merck | 2 | $33 |
| Abbott | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Novartis | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Verona Pharma, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $13 |
| Cequr Corporation | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,934 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 57 | $87,071 |
| EliquisApixaban | 69 | $71,172 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 75 | $66,794 |
| OzempicSemaglutide | 38 | $44,118 |
| JanuviaSitagliptin Phosphate | 39 | $40,415 |
| XareltoRivaroxaban | 34 | $35,206 |
| JanumetSitagliptin Phos/Metformin Hcl | 28 | $34,345 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 22 | $19,858 |
| JardianceEmpagliflozin | 18 | $18,788 |
| V-Go 20Sub-Q Insulin Device, 20 Unit | 30 | $17,457 |
| MyrbetriqMirabegron | 11 | $14,130 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $13,469 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 22 | $13,097 |
| FarxigaDapagliflozin Propanediol | 13 | $11,401 |
| LinzessLinaclotide | 11 | $8,948 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet, Janumet Xr | $33 | $94,61789 claims |
| Lilly USA, LLCTrulicity, Humalog | $76 | $89,62369 claims |
| PfizerEliquis | $243 | $71,17269 claims |
| GSKTrelegy Ellipta | $241 | $66,79475 claims |
| Novo NordiskOzempic | $460 | $44,11838 claims |
| Johnson & JohnsonXarelto | $66 | $35,20634 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $482 | $31,88540 claims |
| AstraZenecaFarxiga, Symbicort | $771 | $14,32424 claims |
| Astellas Pharma US IncMyrbetriq | $74 | $14,13011 claims |
| AbbVieLinzess, Synthroid | $505 | $14,07671 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Norfolk
- Melissa AlcoxNorfolk$73K
- Hillary HartungNorfolk$62K
- Stephanie HadleyNorfolk$15K
- Danielle JohnsonNorfolk$13K
- Ericka ThompsonNorfolk$13K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Lindsay TomReston$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.